{"id":4026,"date":"2011-04-20T13:48:00","date_gmt":"2011-04-20T13:48:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=4026"},"modified":"2021-07-09T11:24:02","modified_gmt":"2021-07-09T11:24:02","slug":"effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/","title":{"rendered":"Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants."},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Yoshino+T&amp;cauthor_id=21311190\">Takuya Yoshino<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21311190\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Nakase+H&amp;cauthor_id=21311190\">Hiroshi Nakase<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Matsuura+M&amp;cauthor_id=21311190\">Minoru Matsuura<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Matsumura+K&amp;cauthor_id=21311190\">Kayoko Matsumura<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Honzawa+Y&amp;cauthor_id=21311190\">Yusuke Honzawa<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fukuchi+T&amp;cauthor_id=21311190\">Takumi Fukuchi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Watanabe+K&amp;cauthor_id=21311190\">Kenji Watanabe<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Murano+M&amp;cauthor_id=21311190\">Mitsuyuki Murano<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tsujikawa+T&amp;cauthor_id=21311190\">Tomoyuki Tsujikawa<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Fukunaga+K&amp;cauthor_id=21311190\">Ken Fukunaga<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Matsumoto+T&amp;cauthor_id=21311190\">Takayuki Matsumoto<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Chiba+T&amp;cauthor_id=21311190\">Tsutomu Chiba<\/a>, Digestion. 2011;84(1):3-9.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>The colectomy ratio tends to be high in refractory UC patients with recurrent CMV reactivation or infection. Therefore, GMA might be a safe and effective treatment for UC patients positive for CMV because it does not induce CMV reactivation.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21311190\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/21311190\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/repository.kulib.kyoto-u.ac.jp\/dspace\/handle\/2433\/183987\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/repository.kulib.kyoto-u.ac.jp\/dspace\/handle\/2433\/183987<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Takuya Yoshino&nbsp;1,&nbsp;Hiroshi Nakase,&nbsp;Minoru Matsuura,&nbsp;Kayoko Matsumura,&nbsp;Yusuke Honzawa,&nbsp;Takumi Fukuchi,&nbsp;Kenji Watanabe,&nbsp;Mitsuyuki Murano,&nbsp;Tomoyuki Tsujikawa,&nbsp;Ken Fukunaga,&nbsp;Takayuki Matsumoto,&nbsp;Tsutomu Chiba, Digestion. 2011;84(1):3-9. The colectomy ratio tends to be high in refractory UC patients with recurrent CMV reactivation or infection. Therefore, GMA might be a safe and effective treatment for UC patients positive for CMV because it does not induce CMV reactivation. https:\/\/pubmed.ncbi.nlm.nih.gov\/21311190\/ [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[147,207,311,306],"class_list":["post-4026","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-cytomegalovirus","scientific_tags-special-situations","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Takuya Yoshino&nbsp;1,&nbsp;Hiroshi Nakase,&nbsp;Minoru Matsuura,&nbsp;Kayoko Matsumura,&nbsp;Yusuke Honzawa,&nbsp;Takumi Fukuchi,&nbsp;Kenji Watanabe,&nbsp;Mitsuyuki Murano,&nbsp;Tomoyuki Tsujikawa,&nbsp;Ken Fukunaga,&nbsp;Takayuki Matsumoto,&nbsp;Tsutomu Chiba, Digestion. 2011;84(1):3-9. The colectomy ratio tends to be high in refractory UC patients with recurrent CMV reactivation or infection. Therefore, GMA might be a safe and effective treatment for UC patients positive for CMV because it does not induce CMV reactivation. https:\/\/pubmed.ncbi.nlm.nih.gov\/21311190\/ [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:24:02+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/\",\"name\":\"Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2011-04-20T13:48:00+00:00\",\"dateModified\":\"2021-07-09T11:24:02+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/","og_locale":"es_ES","og_type":"article","og_title":"Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants. - Adacyte","og_description":"Takuya Yoshino&nbsp;1,&nbsp;Hiroshi Nakase,&nbsp;Minoru Matsuura,&nbsp;Kayoko Matsumura,&nbsp;Yusuke Honzawa,&nbsp;Takumi Fukuchi,&nbsp;Kenji Watanabe,&nbsp;Mitsuyuki Murano,&nbsp;Tomoyuki Tsujikawa,&nbsp;Ken Fukunaga,&nbsp;Takayuki Matsumoto,&nbsp;Tsutomu Chiba, Digestion. 2011;84(1):3-9. The colectomy ratio tends to be high in refractory UC patients with recurrent CMV reactivation or infection. Therefore, GMA might be a safe and effective treatment for UC patients positive for CMV because it does not induce CMV reactivation. https:\/\/pubmed.ncbi.nlm.nih.gov\/21311190\/ [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:24:02+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/","name":"Effect and Safety of Granulocyte-Monocyte Adsorption Apheresis for Patients with Ulcerative Colitis Positive for Cytomegalovirus in Comparison with Immunosuppressants. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2011-04-20T13:48:00+00:00","dateModified":"2021-07-09T11:24:02+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/effect-and-safety-of-granulocyte-monocyte-adsorption-apheresis-for-patients-with-ulcerative-colitis-positive-for-cytomegalovirus-in-comparison-with-immunosuppressants\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/4026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=4026"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=4026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}